Hartmut Goldschmidt

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 97

Top Topics

Multiple Myeloma

Newly Diagnosed

Top Venues

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Manuela Hummel, Thomas Hielscher, Martina Emde-Rajaratnam, Hans J Salwender, Susanne Beck, Christof Scheid, Uta Bertsch, Hartmut Goldschmidt, Anna Jauch, Jérôme Moreaux, Anja Seckinger, Dirk Hose
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation. JCO precision oncology 8 (2024)
Molly Went, Laura Duran-Lozano, Gisli Hreinn Halldorsson, Andrea Gunnell, Nerea Ugidos-Damboriena, Philip J Law, Ludvig Ekdahl, Amit Sud, Gudmar Thorleifsson, Malte Thodberg, Thorunn Asta Olafsdottir, Antton Lamarca-Arrizabalaga, Caterina Cafaro, Abhishek Niroula, Ram Ajore, Aitzkoa Lopez de Lapuente Portilla, Zain Ali, Maroulio Pertesi, Hartmut Goldschmidt, Lilja Stefansdottir, Sigurdur Y Kristinsson, Simon N Stacey, Thorvardur J Love, Saemundur Rognvaldsson, Roman Hájek, Pavel Vodicka, Ulrika Pettersson-Kymmer, Florentin Späth, Carolina D Schinke, Frits Van Rhee, Patrick Sulem, Egil Ferkingstad, Grimur Hjorleifsson Eldjarn, Ulf-Henrik Mellqvist, Ingileif Jónsdóttir, Gareth J Morgan, Pieter Sonneveld, Anders Waage, Niels Weinhold, Hauke Thomsen, Asta Försti, Markus Hansson, Annette Juul Vangsted, Unnur Thorsteinsdottir, Kari Hemminki, Martin F Kaiser, Thorunn Rafnar, Kári Stefánsson, Richard S Houlston, Björn Nilsson
Deciphering the genetics and mechanisms of predisposition to multiple myeloma. Nature communications 15 (1) (2024)
Anja Greinacher, Rea Kuehl, Elias Karl Mai, Hartmut Goldschmidt, Joachim Wiskemann, Anna Fleischer, Leo Rasche, Ulrike Dapunt, Imad Maatouk
The impact of divergent forms of social support on health-related quality of life in patients with multiple myeloma and its precursor states. Journal of cancer research and clinical oncology 150 (2) (2024)
Anthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu, Marcella Kaddoura, Marc-Andrea Bärtsch, Kylee H Maclachlan, Monika Chojnacka, Benjamin T Diamond, Lukas John, Philipp Reichert, Stefanie Huhn, Patrick Blaney, Dylan Gagler, Karsten Rippe, Yanming Zhang, Ahmet Dogan, Alexander M Lesokhin, Faith Davies, Hartmut Goldschmidt, Roland Fenk, Katja C Weisel, Elias Karl Mai, Neha Korde, Gareth J Morgan, Saad Usmani, Carl Ola Landgren, Marc S Raab, Niels Weinhold, Francesco Maura
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma. Blood 144 (7) (2024)
Carl Ola Landgren, Thomas J Prior, Tara Masterson, Christoph Heuck, Orlando F Bueno, Ajeeta B Dash, Hermann Einsele, Hartmut Goldschmidt, Stefan Knop, Cong Li, Ulf-Henrik Mellqvist, Ian McFadden, Corina Oprea, Jeremy A Ross, Mihaela Talpes, Jay R Hydren, Jennifer M Ahlstrom, Dickran Kazandjian, Niels Weinhold, Rick Zhang, Maryalice Stetler-Stevenson, Gerald Marti, Sean M Devlin
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma. Blood 144 (4) (2024)
Carl Ola Landgren, Thomas J Prior, Tara Masterson, Christoph Heuck, Orlando F Bueno, Ajeeta B Dash, Hermann Einsele, Hartmut Goldschmidt, Stefan Knop, Cong Li, Ulf-Henrik Mellqvist, Ian McFadden, Corina Oprea, Jeremy A Ross, Mihaela Talpes, Jay R Hydren, Jennifer M Ahlstrom, Dickran Kazandjian, Niels Weinhold, Rick Zhang, Maryalice Stetler-Stevenson, Gerald Marti, Sean M Devlin
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma. Blood 144 (4) (2024)
Kosima Zuern, Thomas Hielscher, Annika Werly, Iris Breitkreutz, Sandra Sauer, Marc-Steffen Raab, Carsten Müller-Tidow, Hartmut Goldschmidt, Elias Karl Mai
Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance. Blood cancer journal 14 (1) (2024)
Anja Greinacher, Rea Kuehl, Elias Karl Mai, Hartmut Goldschmidt, Joachim Wiskemann, Anna Fleischer, Leo Rasche, Ulrike Dapunt, Imad Maatouk
The impact of divergent forms of social support on health-related quality of life in patients with multiple myeloma and its precursor states. Journal of cancer research and clinical oncology 150 (2) (2024)
Anja Greinacher, Rea Kuehl, Elias Karl Mai, Hartmut Goldschmidt, Joachim Wiskemann, Anna Fleischer, Leo Rasche, Ulrike Dapunt, Imad Maatouk
The impact of divergent forms of social support on health-related quality of life in patients with multiple myeloma and its precursor states. Journal of cancer research and clinical oncology 150 (2) (2024)
Anja Seckinger, Hans Salwender, Hans Martin, Christof Scheid, Thomas Hielscher, Uta Bertsch, Manuela Hummel, Anna Jauch, Wolfgang Knauf, Martina Emde-Rajaratnam, Susanne Beck, Kai Neben, Jan Dührig, Walter Lindemann, Ingo G H Schmidt-Wolf, Mathias Hänel, Igor W Blau, Katja Weisel, Niels Weinhold, Marc S Raab, Hartmut Goldschmidt, Mimi Choon-Quinones, Dirk Hose
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries. International journal of molecular sciences 25 (12) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Anja Greinacher, Rea Kuehl, Elias Karl Mai, Hartmut Goldschmidt, Joachim Wiskemann, Anna Fleischer, Leo Rasche, Ulrike Dapunt, Imad Maatouk
The impact of divergent forms of social support on health-related quality of life in patients with multiple myeloma and its precursor states. Journal of cancer research and clinical oncology 150 (2) (2024)
Anja Greinacher, Rea Kuehl, Elias Karl Mai, Hartmut Goldschmidt, Joachim Wiskemann, Anna Fleischer, Leo Rasche, Ulrike Dapunt, Imad Maatouk
The impact of divergent forms of social support on health-related quality of life in patients with multiple myeloma and its precursor states. Journal of cancer research and clinical oncology 150 (2) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Molly Went, Laura Duran-Lozano, Gisli Hreinn Halldorsson, Andrea Gunnell, Nerea Ugidos-Damboriena, Philip J Law, Ludvig Ekdahl, Amit Sud, Gudmar Thorleifsson, Malte Thodberg, Thorunn Asta Olafsdottir, Antton Lamarca-Arrizabalaga, Caterina Cafaro, Abhishek Niroula, Ram Ajore, Aitzkoa Lopez de Lapuente Portilla, Zain Ali, Maroulio Pertesi, Hartmut Goldschmidt, Lilja Stefansdottir, Sigurdur Y Kristinsson, Simon N Stacey, Thorvardur J Love, Saemundur Rognvaldsson, Roman Hájek, Pavel Vodicka, Ulrika Pettersson-Kymmer, Florentin Späth, Carolina D Schinke, Frits Van Rhee, Patrick Sulem, Egil Ferkingstad, Grimur Hjorleifsson Eldjarn, Ulf-Henrik Mellqvist, Ingileif Jónsdóttir, Gareth J Morgan, Pieter Sonneveld, Anders Waage, Niels Weinhold, Hauke Thomsen, Asta Försti, Markus Hansson, Annette Juul Vangsted, Unnur Thorsteinsdottir, Kari Hemminki, Martin F Kaiser, Thorunn Rafnar, Kári Stefánsson, Richard S Houlston, Björn Nilsson
Deciphering the genetics and mechanisms of predisposition to multiple myeloma. Nature communications 15 (1) (2024)
Anja Greinacher, Rea Kuehl, Elias Karl Mai, Hartmut Goldschmidt, Joachim Wiskemann, Anna Fleischer, Leo Rasche, Ulrike Dapunt, Imad Maatouk
The impact of divergent forms of social support on health-related quality of life in patients with multiple myeloma and its precursor states. Journal of cancer research and clinical oncology 150 (2) (2024)
Anthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu, Marcella Kaddoura, Marc-Andrea Baertsch, Kylee H Maclachlan, Monika Chojnacka, Benjamin T Diamond, Lukas John, Philipp Reichert, Stefanie Huhn, Patrick Blaney, Dylan C Gagler, Karsten Rippe, Yanming Zhang, Ahmet Dogan, Alexander M Lesokhin, Faith E Davies, Hartmut Goldschmidt, Roland Fenk, Katja C Weisel, Elias Karl Mai, Neha Korde, Gareth J Morgan, Saad Z Usmani, Carl Ola Landgren, Marc S Raab, Niels Weinhold, Francesco Maura
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma. Blood (2024)
Anja Greinacher, Rea Kuehl, Elias Karl Mai, Hartmut Goldschmidt, Joachim Wiskemann, Anna Fleischer, Leo Rasche, Ulrike Dapunt, Imad Maatouk
The impact of divergent forms of social support on health-related quality of life in patients with multiple myeloma and its precursor states. Journal of cancer research and clinical oncology 150 (2) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Hauke Thomsen, Subhayan Chattopadhyay, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Roman Hájek, Göran Hallmans, Ulrika Pettersson-Kymmer, Florentin Späth, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance. Blood cancer journal 14 (1) (2024)
Anja Greinacher, Rea Kuehl, Elias Karl Mai, Hartmut Goldschmidt, Joachim Wiskemann, Anna Fleischer, Leo Rasche, Ulrike Dapunt, Imad Maatouk
The impact of divergent forms of social support on health-related quality of life in patients with multiple myeloma and its precursor states. Journal of cancer research and clinical oncology 150 (2) (2024)
Hauke Thomsen, Subhayan Chattopadhyay, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Roman Hájek, Göran Hallmans, Ulrika Pettersson-Kymmer, Florentin Späth, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance. Blood cancer journal 14 (1) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Carl Ola Landgren, Thomas J Prior, Tara Masterson, Christoph Heuck, Orlando F Bueno, Ajeeta B Dash, Hermann Einsele, Hartmut Goldschmidt, Stefan Knop, Cong Li, Ulf-Henrik Mellqvist, Ian McFadden, Corina Oprea, Jeremy A Ross, Mihaela Talpes, Jay R Hydren, Jenny Ahlstrom, Dickran Kazandjian, Niels Weinhold, Rick Zhang, Maryalice Stetler-Stevenson, Gerald E Marti, Sean M Devlin
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical endpoint for multiple myeloma. Blood (2024)
Anja Greinacher, Rea Kuehl, Elias Karl Mai, Hartmut Goldschmidt, Joachim Wiskemann, Anna Fleischer, Leo Rasche, Ulrike Dapunt, Imad Maatouk
The impact of divergent forms of social support on health-related quality of life in patients with multiple myeloma and its precursor states. Journal of cancer research and clinical oncology 150 (2) (2024)
Kosima Zuern, Thomas Hielscher, Annika Werly, Iris Breitkreutz, Sandra Sauer, Marc-Steffen Raab, Carsten Müller-Tidow, Hartmut Goldschmidt, Elias Karl Mai
Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance. Blood cancer journal 14 (1) (2024)
Anja Seckinger, Hans Salwender, Hans Martin, Christof Scheid, Thomas Hielscher, Uta Bertsch, Manuela Hummel, Anna Jauch, Wolfgang Knauf, Martina Emde-Rajaratnam, Susanne Beck, Kai Neben, Jan Dührig, Walter Lindemann, Ingo G H Schmidt-Wolf, Mathias Hänel, Igor W Blau, Katja Weisel, Niels Weinhold, Marc S Raab, Hartmut Goldschmidt, Mimi Choon-Quinones, Dirk Hose
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries. International journal of molecular sciences 25 (12) (2024)
Anja Seckinger, Hans Salwender, Hans Martin, Christof Scheid, Thomas Hielscher, Uta Bertsch, Manuela Hummel, Anna Jauch, Wolfgang Knauf, Martina Emde-Rajaratnam, Susanne Beck, Kai Neben, Jan Dührig, Walter Lindemann, Ingo G H Schmidt-Wolf, Mathias Hänel, Igor W Blau, Katja Weisel, Niels Weinhold, Marc S Raab, Hartmut Goldschmidt, Mimi Choon-Quinones, Dirk Hose
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries. International journal of molecular sciences 25 (12) (2024)
Molly Went, Laura Duran-Lozano, Gisli Hreinn Halldorsson, Andrea Gunnell, Nerea Ugidos-Damboriena, Philip J Law, Ludvig Ekdahl, Amit Sud, Gudmar Thorleifsson, Malte Thodberg, Thorunn Asta Olafsdottir, Antton Lamarca-Arrizabalaga, Caterina Cafaro, Abhishek Niroula, Ram Ajore, Aitzkoa Lopez de Lapuente Portilla, Zain Ali, Maroulio Pertesi, Hartmut Goldschmidt, Lilja Stefansdottir, Sigurdur Y Kristinsson, Simon N Stacey, Thorvardur J Love, Saemundur Rognvaldsson, Roman Hájek, Pavel Vodicka, Ulrika Pettersson-Kymmer, Florentin Späth, Carolina D Schinke, Frits Van Rhee, Patrick Sulem, Egil Ferkingstad, Grimur Hjorleifsson Eldjarn, Ulf-Henrik Mellqvist, Ingileif Jónsdóttir, Gareth J Morgan, Pieter Sonneveld, Anders Waage, Niels Weinhold, Hauke Thomsen, Asta Försti, Markus Hansson, Annette Juul Vangsted, Unnur Thorsteinsdottir, Kari Hemminki, Martin F Kaiser, Thorunn Rafnar, Kári Stefánsson, Richard S Houlston, Björn Nilsson
Deciphering the genetics and mechanisms of predisposition to multiple myeloma. Nature communications 15 (1) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M Poos, Britta Besemer, Kaya Miah, Axel Benner, Nicole Becker, Thomas Moehler, Ivana Metzler, Cyrus Khandanpour, Andrea Seidel-Glaetzer, Karolin Trautmann-Grill, Klaus Martin Kortüm, Carsten Muller-Tidow, Gunhild Mechtersheimer, Benjamin Goeppert, Albrecht Stenzinger, Niels Weinhold, Hartmut Goldschmidt, Katja C Weisel, Marc S Raab
A phase II clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma. Blood (2023)
Alexandra M Poos, Nina Prokoph, Moritz Jakob Przybilla, Jan-Philipp Mallm, Simon Steiger, Isabelle Seufert, Lukas John, Stephan M Tirier, Katharina Bauer, Anja Baumann, Jennifer Rohleder, Umair Munawar, Leo Rasche, Klaus Martin Kortüm, Nicola Giesen, Philipp Reichert, Stefanie Huhn, Carsten Muller-Tidow, Hartmut Goldschmidt, Oliver Stegle, Marc S Raab, Karsten Rippe, Niels Weinhold
Resolving therapy resistance mechanisms in multiple myeloma by multi-omics subclone analysis. Blood (2023)
Elias Karl Mai, Thomas Hielscher, Uta Bertsch, Hans J Salwender, Sonja Zweegman, Marc-Steffen Raab, Markus Munder, Lucia Pantani, Katia Mancuso, Peter Brossart, Meral Beksac, Igor W Blau, Jan Dürig, Britta Besemer, Roland Fenk, Peter Reimer, Bronno van der Holt, Mathias Hänel, Ivana von Metzler, Ullrich Graeven, Carsten Muller-Tidow, Mario Boccadoro, Christof Scheid, Meletios- Athanasios Dimopoulos, Jens Hillengass, Katja C Weisel, Michele Cavo, Pieter Sonneveld, Hartmut Goldschmidt
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients. Leukemia (2023)
Lisa B Leypoldt, Maria Gavriatopoulou, Britta Besemer, Hans J Salwender, Marc S Raab, Axel Nogai, Cyrus Khandanpour, Volker Runde, Anna Jauch, Manola Zago, Peter Martus, Hartmut Goldschmidt, Carsten Bokemeyer, Meletios- Athanasios Dimopoulos, Katja C Weisel
Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial. Cancers 15 (18) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Andrew Spencer, Philippe Moreau, Maria-Victoria Mateos-Manteca, Hartmut Goldschmidt, Kenshi Suzuki, Mark-David Levin, Pieter Sonneveld, Robert Z Orlowski, Sung Soo Yoon, Saad Z Usmani, Katja C Weisel, Donna Reece, Tahamtan Ahmadi, Huiling Pei, Wendy Garvin Mayo, Xue Gai, Jodi Carey, J Blake Bartlett, Robin Carson, Meletios-Athanasios A Dimopoulos
Daratumumab in Myeloma Patients With Early or Late Relapse After Initial Therapy: Subgroup Analysis of CASTOR and POLLUX. Blood advances (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Lukas John, Alexandra M Poos, Alexander Brobeil, Carolina D Schinke, Stefanie Huhn, Nina Prokoph, Raphael Lutz, Barbara Wagner, Maurizio Zangari, Stephan M Tirier, Jan-Philipp Mallm, Sabrina Schumacher, Dominik Vonficht, Llorenç Solé-Boldo, Sabine Quick, Simon Steiger, Moritz J Przybilla, Katharina Bauer, Anja Baumann, Stefan Hemmer, Christoph Rehnitz, Christian Lückerath, Christos Sachpekidis, Gunhild Mechtersheimer, Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss, Philipp Reichert, Bart Barlogie, Carsten Muller-Tidow, Hartmut Goldschmidt, Jens Hillengass, Leo Rasche, Simon F Haas, Frits Van Rhee, Karsten Rippe, Marc-Steffen Raab, Sandra Sauer, Niels Weinhold
Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level. Nature communications 14 (1) (2023)
Cirino Botta, Cristina Perez, Marta Larrayoz, Noemi Puig, María-Teresa Cedena, Rosalinda Termini, Ibai Goicoechea, Sara Rodriguez, Aintzane Zabaleta, Aitziber Lopez, Sarai Sarvide, Laura Blanco, Daniele M Papetti, Marco Salvatore Nobile, Daniela Besozzi, Massimo Gentile, Pierpaolo Correale, Sergio Siragusa, Albert Oriol, Maria Esther González-Garcia, Anna Sureda, Felipe de Arriba, Rafael Rios-Tamayo, José María M Moraleda, Mercedes Gironella, Miguel T Hernandez, Joan Bargay, Luis Palomera, Albert Pérez-Montaña, Hartmut Goldschmidt, Hervé Avet-Loiseau, Aldo M Roccaro, Alberto Orfao, Joaquin Martinez-Lopez, Laura Rosinol, Juan-José Lahuerta, Joan Bladé, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Jose-Angel Martinez-Climent, Juan José Lahuerta, null null, null null
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Nature communications 14 (1) (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M Poos, Britta Besemer, Kaya Miah, Axel Benner, Nicole Becker, Thomas Moehler, Ivana Metzler, Cyrus Khandanpour, Andrea Seidel-Glaetzer, Karolin Trautmann-Grill, Klaus Martin Kortüm, Carsten Muller-Tidow, Gunhild Mechtersheimer, Benjamin Goeppert, Albrecht Stenzinger, Niels Weinhold, Hartmut Goldschmidt, Katja C Weisel, Marc S Raab
A phase II clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma. Blood (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Lisa B Leypoldt, Diana Tichy, Britta Besemer, Mathias Hänel, Marc-Steffen Raab, Christoph Mann, Markus Munder, Hans Christian Reinhardt, Axel Nogai, Martin Görner, Yon-Dschun Ko, Maike de Wit, Hans J Salwender, Christof Scheid, Ullrich Graeven, Rudolf Peceny, Peter Staib, Annette Dieing, Hermann Einsele, Anna Jauch, Michael Hundemer, Manola Zago, Ema Požek, Axel Benner, Carsten Bokemeyer, Hartmut Goldschmidt, Katja C Weisel
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Amelie Boquoi, Aristoteles Giagounidis, Hartmut Goldschmidt, Michael Heinsch, Mathias J Rummel, Nicolaus Kröger, Elias Karl Mai, Judith Strapatsas, Rainer Haas, Guido Kobbe
Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation-Results from the LenaMain Trial (NCT00891384). Cancers 15 (21) (2023)
Angelica Macauda, Klara Briem, Alyssa Clay-Gilmour, Wendy Cozen, Asta Försti, Matteo Giaccherini, Chiara Corradi, Juan Sainz, Yasmeen Niazi, Rob Ter Horst, Yang Li, Mihai M Netea, Ulla Vogel, Kari Hemminki, Susan L Slager, Judit Varkonyi, Vibeke Andersen, Elzbieta Iskierka-Jazdzewska, Joaquin Martinez Lopez, Jan Zaucha, Nicola J Camp, S Vincent Rajkumar, Agnieszka Druzd-Sitek, Parveen Bhatti, Stephen J Chanock, Shaji K Kumar, Edyta Subocz, Grzegorz Mazur, Stefano Landi, Mitchell J Machiela, Andrés Jerez, Aaron D Norman, Michelle A T Hildebrandt, Katalin Kadar, Sonja I Berndt, Elad Ziv, Gabriele Buda, Arnon Nagler, Charles Dumontet, Malgorzata Raźny, Marzena Wątek, Aleksandra Butrym, Norbert Grzasko, Marek Dudzinski, Malwina Rybicka-Ramos, Eva-Laure Matera, Miriam Santero, Hartmut Goldschmidt, Krzysztof Jamroziak, Artur Jurczyszyn, Esther Clavero, Graham G Giles, Matteo Pelosini, Daria Zawirska, Marcin Kruszewski, Herlander Marques, Eva Haastrup, José Manuel Sánchez-Maldonado, Uta Bertsch, Marcin Rymko, Marc-Steffen Raab, Elizabeth E Brown, Jonathan N Hofmann, Celine M Vachon, Daniele Campa, Frederico Canzian
Identification of novel genetic loci for risk of multiple myeloma by functional annotation. Leukemia (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Maria-Victoria Mateos-Manteca, Katja C Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Michele Cavo, Ravi Vij, Joanne Lindsey-Hill, Dominik Dytfeld, Emanuele Angelucci, Aurore Perrot, Reuben Benjamin, Niels W C J van de Donk, Enrique M Ocio, Christof Scheid, Francesca Gay, Wilfried Roeloffzen, Paula Rodriguez-Otero, Annemiek Broijl, Anna Potamianou, Caline Sakabedoyan, Maria Semerjian, Sofia Keim, Vadim Strulev, Jordan M Schecter, Martin Vogel, Robert Wapenaar, Tonia Nesheiwat, Jesús San F Miguel, Pieter Sonneveld, Hermann Einsele, Philippe Moreau
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma. Leukemia 36 (5) (2022)
Thierry Facon, Gordon Cook, Saad Z Usmani, Cyrille Hulin, Shaji K Kumar, Torben Plesner, Cyrille Touzeau, Nizar J Bahlis, Supratik Basu, Hareth Nahi, Hartmut Goldschmidt, Hang Quach, Mohamad Mohty, Christopher P Venner, Katja C Weisel, Noopur Raje, Benjamin Hebraud, Karim Belhadj-Merzoug, Lotfi Benboubker, Olivier Decaux, Salomon Manier, Denis Caillot, Jon Ukropec, Huiling Pei, Rian Van Rampelbergh, Clarissa M Uhlar, Rachel Kobos, Sonja Zweegman
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA. Leukemia 36 (4) (2022)
Katja Weisel, Ajay K Nooka, Evangelos Terpos, Andrew Spencer, Hartmut Goldschmidt, Franziska Dirnberger, Lucy DeCosta, Akeem Yusuf, Shaji K Kumar
Carfilzomib 56 mg/m 2 twice-weekly in combination with dexamethasone and daratumumab (KdD) versus daratumumab in combination with bortezomib and dexamethasone (DVd): a matching-adjusted indirect treatment comparison. Leukemia & lymphoma 63 (8) (2022)
Yasmeen Niazi, Nagarajan Paramasivam, Joanna Blocka, Abhishek Kumar, Stefanie Huhn, Matthias Schlesner, Niels Weinhold, Rolf Sijmons, Mirjam De Jong, Brian Durie, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma. Cells 12 (1) (2022)
Yasmeen Niazi, Nagarajan Paramasivam, Joanna Blocka, Abhishek Kumar, Stefanie Huhn, Matthias Schlesner, Niels Weinhold, Rolf Sijmons, Mirjam De Jong, Brian Durie, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma. Cells 12 (1) (2022)
Yasmeen Niazi, Nagarajan Paramasivam, Joanna Blocka, Abhishek Kumar, Stefanie Huhn, Matthias Schlesner, Niels Weinhold, Rolf Sijmons, Mirjam De Jong, Brian Durie, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma. Cells 12 (1) (2022)
Alyssa Clay-Gilmour, Subhayan Chattopadhyay, Michelle A T Hildebrandt, Hauke Thomsen, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Christian Langer, Roman Hájek, Göran Hallmans, Ulrika Pettersson-Kymmer, Claes Ohlsson, Florentin Späth, Richard S Houlston, Hartmut Goldschmidt, Elisabet E Manasanch, Aaron Norman, Shaji K Kumar, Sundararajan Vincent Rajkumar, Susan L Slager, Asta Försti, Celine M Vachon, Kari Hemminki
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6. Blood cancer journal 12 (4) (2022)
Henrike Staemmler, Sandra Sauer, Emma Pauline Kreutzer, Juliane Brandt, Karin Jordan, Michael Kreuter, Mark Kriegsmann, Hartmut Goldschmidt, Carsten Müller-Tidow, Gerlinde Egerer, Katharina Kriegsmann
Quality of Online Information on Multiple Myeloma Available for Laypersons. Current oncology (Toronto, Ont.) 29 (7) (2022)
Rosalinda Termini, David Zihala, Evangelos Terpos, Albert Perez-Montaña, Tomas Jelinek, Marc-Steffen Raab, Niels Weinhold, Elias Karl Mai, Anna Luise Grab, Jill Corre, François Vergez, Antonio Sacco, Marco Chiarini, Viviana Giustini, Alessandra Tucci, Sara Rodriguez, Cristina Moreno, Cristina Perez, Catarina Maia, Esperanza Martin-Sanchez, Camilla Guerrero, Cirino Botta, Juan-José Garcés, Aitziber Lopez, Luis Esteban Tamariz-Amador, Felipe Prosper, Joan Bargay, Maria-Elena Cabezudo, Enrique María Ocio, Roman Hájek, Joaquin Martinez Lopez, Fernando Solano, Rebeca Iglesias, Artur Paiva, Catarina Geraldes, Helena Vitoria, Clara Gomez, Felipe De Arriba, Heinz Ludwig, Antoni Garcia-Guiñon, María Casanova, Adrian Alegre, Valentín Cabañas, Maialen Sirvent, Albert Ortiol, Javier de la Rubia, Jose-Ángel Hernández-Rivas, Luis Palomera, Maria Sarasa, Pablo Rios, Noemi Puig, Maria-Victoria Mateos-Manteca, Juan A Flores-Montero, Alberto Orfao, Hartmut Goldschmidt, Herve Avet-Loiseau, Aldo M Roccaro, Jesús San F Miguel, Juan José Lahuerta, null null
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Yasmeen Niazi, Nagarajan Paramasivam, Joanna Blocka, Abhishek Kumar, Stefanie Huhn, Matthias Schlesner, Niels Weinhold, Rolf Sijmons, Mirjam De Jong, Brian Durie, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma. Cells 12 (1) (2022)
Angelica Macauda, Alyssa Clay-Gilmour, Thomas Hielscher, Michelle A T Hildebrandt, Marcin Kruszewski, Robert Z Orlowski, Shaji K Kumar, Elad Ziv, Enrico Orciuolo, Elizabeth E Brown, Asta Försti, Rosalie G Waller, Mitchell J Machiela, Stephen J Chanock, Nicola J Camp, Marcin Rymko, Małgorzata Raźny, Wendy Cozen, Judit Várkonyi, Chiara Piredda, Matteo Pelosini, Alem A Belachew, Edyta Subocz, Kari Hemminki, Malwina Rybicka-Ramos, Graham G Giles, Jonathan Beesley, Jonathan N Hofmann, Jan Maciej Zaucha, Annette Juul Vangsted, Hartmut Goldschmidt, Sundararajan Vincent Rajkumar, Waldemar Tomczak, Juan Sainz, Aleksandra Butrym, Marzena Wątek, Elżbieta Iskierka-Jazdzewska, Gabriele Buda, Dennis P Robinson, Artur Jurczyszyn, Marek Dudziński, Joaquin Martinez Lopez, Jason P Sinnwell, Susan L Slager, Krzysztof Jamroziak, Rui Manuel Vieira Reis, Niels Weinhold, Parveen Bhatti, Luis G Carvajal Carmona, Daria Zawirska, Aaron D Norman, Grzegorz Mazur, Sonja I Berndt, Daniele Campa, Celine M Vachon, Frederico Canzian
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma? Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (9) (2022)
Ram Ajore, Abhishek Niroula, Maroulio Pertesi, Caterina Cafaro, Malte Thodberg, Molly Went, Erik L Bao, Laura Duran-Lozano, Aitzkoa Lopez de Lapuente Portilla, Thorunn Asta Olafsdottir, Nerea Ugidos-Damboriena, Olafur Magnusson, Mehmet Kemal Samur, Caleb A Lareau, Gisli Hreinn Halldorsson, Gudmar Thorleifsson, Gudmundur L Norddahl, Kristbjorg Gunnarsdottir, Asta Försti, Hartmut Goldschmidt, Kari Hemminki, Frits van Rhee, Scott Kimber, Adam S Sperling, Martin F Kaiser, Kenneth C Anderson, Ingileif Jónsdóttir, Nikhil C Munshi, Thorunn Rafnar, Anders Waage, Niels Weinhold, Unnur Thorsteinsdottir, Vijay G Sankaran, Kári Stefánsson, Richard S Houlston, Björn Nilsson
Functional dissection of inherited non-coding variation influencing multiple myeloma risk. Nature communications 13 (1) (2022)
Katharina Kriegsmann, Calin Manta, Ricarda Schwab, Elias Karl Mai, Marc S Raab, Hans J Salwender, Roland Fenk, Britta Besemer, Jan Dürig, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Anne M Asemissen, Bernhard Heilmeier, Uta Bertsch, Stefanie Huhn, Carsten Muller-Tidow, Hartmut Goldschmidt, Michael Hundemer
Bone Marrow and Peripheral Blood Aberrant Plasma Cell Assessment by Next-Generation Flow Cytometry in MM Patients. Blood advances (2022)
Ram Ajore, Abhishek Niroula, Maroulio Pertesi, Caterina Cafaro, Malte Thodberg, Molly Went, Erik L Bao, Laura Duran-Lozano, Aitzkoa Lopez de Lapuente Portilla, Thorunn Asta Olafsdottir, Nerea Ugidos-Damboriena, Olafur Magnusson, Mehmet Kemal Samur, Caleb A Lareau, Gisli Hreinn Halldorsson, Gudmar Thorleifsson, Gudmundur L Norddahl, Kristbjorg Gunnarsdottir, Asta Försti, Hartmut Goldschmidt, Kari Hemminki, Frits van Rhee, Scott Kimber, Adam S Sperling, Martin F Kaiser, Kenneth C Anderson, Ingileif Jónsdóttir, Nikhil C Munshi, Thorunn Rafnar, Anders Waage, Niels Weinhold, Unnur Thorsteinsdottir, Vijay G Sankaran, Kári Stefánsson, Richard S Houlston, Björn Nilsson
Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma risk. Nature communications 13 (1) (2022)
Ram Ajore, Abhishek Niroula, Maroulio Pertesi, Caterina Cafaro, Malte Thodberg, Molly Went, Erik L Bao, Laura Duran-Lozano, Aitzkoa Lopez de Lapuente Portilla, Thorunn Asta Olafsdottir, Nerea Ugidos-Damboriena, Olafur Magnusson, Mehmet Kemal Samur, Caleb A Lareau, Gisli Hreinn Halldorsson, Gudmar Thorleifsson, Gudmundur L Norddahl, Kristbjorg Gunnarsdottir, Asta Försti, Hartmut Goldschmidt, Kari Hemminki, Frits van Rhee, Scott Kimber, Adam S Sperling, Martin F Kaiser, Kenneth C Anderson, Ingileif Jónsdóttir, Nikhil C Munshi, Thorunn Rafnar, Anders Waage, Niels Weinhold, Unnur Thorsteinsdottir, Vijay G Sankaran, Kári Stefánsson, Richard S Houlston, Björn Nilsson
Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma risk. Nature communications 13 (1) (2022)
Mattia D'Agostino, David A Cairns, Juan-José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos-Manteca, Daniele Dall'Olio, Niels W C J van de Donk, Graham H Jackson, Serena Rocchi, Hans J Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone C Castellani, Francesca Bonello, Andrea Capra, Elias Karl Mai, Jan Dürig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F Kaiser, Hartmut Goldschmidt, Jesús María Hernández-Rivas, Alessandra Larocca, Curly T C M Morris, Jesús San F Miguel, Mario Boccadoro, Pieter Sonneveld
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Cirino Botta, Catarina Da Silva Maia, Juan-José Garcés, Rosalinda Termini, Cristina Perez, Irene Manrique, Leire Burgos, Aintzane Zabaleta, Diego Alignani, Sarai Sarvide, Juana Merino, Noemi Puig, Maria-Teresa Cedena, Marco Rossi, Pierfrancesco Tassone, Massimo Gentile, Pierpaolo Correale, Ivan M Borrello, Evangelos Terpos, Tomas Jelinek, Artur Paiva, Aldo M Roccaro, Hartmut Goldschmidt, Herve Avet-Loiseau, Laura Rosinol, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Juan José Lahuerta
FlowCT for the analysis of large immunophenotypic datasets and biomarker discovery in cancer immunology. Blood advances (2021)
Markus Wennmann, Thomas Hielscher, Laurent Kintzelé, Bjoern H Menze, Georg Langs, Maximilian Merz, Sandra Sauer, Hans-Ulrich Kauczor, Heinz-Peter Schlemmer, Stefan Delorme, Hartmut Goldschmidt, Niels Weinhold, Jens Hillengass, Matthias H Munk
Analyzing Longitudinal wb-MRI Data and Clinical Course in a Cohort of Former Smoldering Multiple Myeloma Patients: Connections between MRI Findings and Clinical Progression Patterns. Cancers 13 (5) (2021)
Raphael Lutz, Mirco Friedrich, Marc Steffen Raab, Niels Weinhold, Hartmut Goldschmidt
Therapeutic Advances Propelled by Deciphering Tumor Biology and Immunology-Highlights of the 8th Heidelberg Myeloma Workshop. Cancers 13 (16) (2021)
Eva-Maria Klein, Diana Tichy, Hans J Salwender, Elias Karl Mai, Jan Duerig, Katja C Weisel, Axel Benner, Uta Bertsch, Mabast Akhavanpoor, Britta Besemer, Markus Munder, Hans-Walter Lindemann, Dirk Hose, Anja Seckinger, Steffen Luntz, Anna Jauch, Ahmet Elmaagacli, Stephan Fuhrmann, Peter Brossart, Martin Goerner, Helga Bernhard, Marc S Raab, Igor W Blau, Mathias Haenel, Christof Scheid, Hartmut Goldschmidt, null On Behalf Of The German-Speaking Myeloma Multicenter Group Gmmg
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial. Cancers 13 (19) (2021)
Eva-Maria Klein, Sandra Sauer, Sabrina Klein, Diana Tichy, Axel Benner, Uta Bertsch, Juliane Brandt, Christoph Kimmich, Hartmut Goldschmidt, Carsten Müller-Tidow, Karin Jordan, Nicola Giesen
Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation. Cancers 13 (14) (2021)
Lisa B Leypoldt, Britta Besemer, Anne Marie Asemissen, Mathias Hänel, Igor Wolfgang Blau, Martin Görner, Yon-Dschun Ko, Hans Christian Reinhardt, Peter Staib, Christoph Mann, Raphael Lutz, Markus Munder, Ullrich Graeven, Rudolf Peceny, Hans J Salwender, Anna Jauch, Manola Zago, Axel Benner, Diana Tichy, Carsten Bokemeyer, Hartmut Goldschmidt, Katja C Weisel
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial. Leukemia (2021)
Sundar Jagannath, Yi Lin, Hartmut Goldschmidt, Donna Reece, Ajay K Nooka, Alicia Senin, Paula Rodriguez-Otero, Ray Powles, Kosei Matsue, Nina Shah, Larry D Anderson, Matthew Streetly, Kimberly Wilson, Hoa Van Le, Arlene S Swern, Amit Agarwal, David S Siegel
KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma. Blood cancer journal 11 (6) (2021)
Stephan M Tirier, Jan-Philipp Mallm, Simon Steiger, Alexandra M Poos, Mohamed H S Awwad, Nicola Giesen, Nicola Casiraghi, Hana Susak, Katharina Bauer, Anja Baumann, Lukas John, Anja Seckinger, Dirk Hose, Carsten Muller-Tidow, Hartmut Goldschmidt, Oliver Stegle, Michael Hundemer, Niels Weinhold, Marc-Steffen Raab, Karsten Rippe
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics. Nature communications 12 (1) (2021)
Charlie N Saunders, Subhayan Chattopadhyay, Stefanie Huhn, Niels Weinhold, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Stefano Landi, Hartmut Goldschmidt, Paolo Milani, Giampaolo Merlini, Dorota Rowcieno, Philip Hawkins, Ute Hegenbart, Giovanni Palladini, Ashutosh Wechalekar, Stefan O Schönland, Asta Försti, Richard Houlston, Kari Hemminki
Search for AL amyloidosis risk factors using Mendelian randomization. Blood advances 5 (13) (2021)
Carlos Fernández de Larrea, Robert Kyle, Laura Rosinol, Juan José Lahuerta, Monika Engelhardt, Saad Z Usmani, Jo Caers, Wilson Gonsalves, Schjesvold Fredrik, Giampaolo Merlini, Suzanne Lentzch, Enrique Ocio, Laurent Garderet, Philippe Moreau, Pieter Sonneveld, Ashraf Badros, Gösta Gahrton, Hartmut Goldschmidt, Sascha A Tuchman, Hermann Einsele, Brian Durie, Baldeep Wirk, Pellegrino Musto, Patrick Hayden, Martin F Kaiser, Jesús San F Miguel, Joan Bladé, Sundararajan Vincent Rajkumar, Maria-Victoria Mateos-Manteca
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood cancer journal 11 (12) (2021)
Marc-Andrea Baertsch, Mathilde Fougereau, Thomas Hielscher, Sandra Sauer, Iris Breitkreutz, Karin Jordan, Carsten Müller-Tidow, Hartmut Goldschmidt, Marc-Steffen Raab, Jens Hillengass, Nicola Giesen
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma. Cancers 13 (18) (2021)
Maximilian Merz, Hartmut Goldschmidt, Parameswaran Hari, Mounzer Agha, Joris Diels, Francesca Ghilotti, Nolen J Perualila, Jedelyn Cabrieto, Benjamin Haefliger, Henrik Sliwka, Jordan M Schecter, Carolyn C Jackson, Yunsi Olyslager, Muhammad Akram, Tonia Nesheiwat, Lenka Kellermann, Sundar Jagannath
Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry. Cancers 13 (23) (2021)
Mohamed H S Awwad, Abdelrahman Mahmoud, Heiko Bruns, Hakim Echchannaoui, Katharina Kriegsmann, Raphael Lutz, Marc S Raab, Uta Bertsch, Markus Munder, Anna Jauch, Katja Weisel, Bettina Maier, Niels Weinhold, Hans Jürgen Salwender, Volker Eckstein, Mathias Hänel, Roland Fenk, Jan Dürig, Benedikt Brors, Axel Benner, Carsten Muller-Tidow, Hartmut Goldschmidt, Michael Hundemer
Selective elimination of immunosuppressive T cells in patients with multiple myeloma. Leukemia 35 (9) (2021)
Hans J Salwender, Ahmet Elmaagacli, Maximilian Merz, Kaya Miah, Axel Benner, Mathias Haenel, Christian Jehn, Elias Karl Mai, Uta Bertsch, Igor W Blau, Christof Scheid, Dirk Hose, Anja Seckinger, Anna Jauch, Marc S Raab, Steffen P Luntz, Britta Besemer, Markus Munder, Peter Brossart, Stephan Fuhrmann, Hans-Walter Lindemann, Katja C Weisel, Jan Duerig, Hartmut Goldschmidt
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial. Leukemia 35 (10) (2021)
Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja C Weisel, Christof Scheid, Ulrich Bernd Keller, Dirk Hose, Florian Bassermann
MCT1 is a Predictive Marker for Lenalidomide Maintenance Therapy in Multiple Myeloma. Blood advances (2021)
Fengjuan Fan, Stefano Malvestiti, Sonia Vallet, Judith Lind, Jose Manuel Garcia-Manteiga, Eugenio Morelli, Qinyue Jiang, Anja Seckinger, Dirk Hose, Hartmut Goldschmidt, Andreas Stadlbauer, Chunyan Sun, Heng Mei, Martin Pecherstorfer, Latifa Bakiri, Erwin F Wagner, Giovanni Tonon, Martin Sattler, Han Yan, Pierfrancesco Tassone, Dirk Jaeger, Klaus Podar
JunB is a key regulator of multiple myeloma bone marrow angiogenesis. Leukemia 35 (12) (2021)
Calogerina Catalano, Nagarajan Paramasivam, Joanna Blocka, Sara Giangiobbe, Stefanie Huhn, Matthias Schlesner, Niels Weinhold, Rolf Sijmons, Mirjam de Jong, Christian Langer, Klaus-Dieter Preuss, Björn Nilsson, Brian Durie, Hartmut Goldschmidt, Obul Reddy Bandapalli, Kari Hemminki, Asta Försti
Characterization of rare germline variants in familial multiple myeloma. Blood cancer journal 11 (2) (2021)
Marc-Andrea Baertsch, Elias Karl Mai, Thomas Hielscher, Uta Bertsch, Hans J Salwender, Markus Munder, Stephan Fuhrmann, Ulrich Dührsen, Peter Brossart, Kai Neben, Jana Schlenzka, Christina Kunz, Marc S Raab, Jens Hillengaß, Anna Jauch, Anja Seckinger, Dirk Hose, Steffen Luntz, Pieter Sonneveld, Henk Lokhorst, Hans Martin, Martin Goerner, Martin Hoffmann, Hans-Walter Lindemann, Helga Bernhard, Igor W Blau, Christof Scheid, Britta Besemer, Katja C Weisel, Mathias Hänel, Jan Dürig, Hartmut Goldschmidt, null null
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma. Blood cancer journal 11 (1) (2021)
Lina Jansen, Maximilian Merz, Monika Engelhardt, Katja Weisel, Christof Scheid, Christian Straka, Christian Langer, Hans Salwender, Hermann Einsele, Nikolaus Kröger, Dietrich W Beelen, Peter Dreger, Hartmut Goldschmidt, Hermann Brenner, null null
Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects. Leukemia & lymphoma 61 (10) (2020)
Maria-Victoria Mateos-Manteca, Shaji K Kumar, Meletios- Athanasios Dimopoulos, Verónica González-Calle, Efstathios Kastritis, Roman Hajek, Carlos Fernández De Larrea, Gareth J Morgan, Giampaolo Merlini, Hartmut Goldschmidt, Catarina Geraldes, Alessandro Gozzetti, Charalampia Kyriakou, Laurent Garderet, Markus Hansson, Elena Zamagni, Dorotea Fantl, Xavier Leleu, Byung-Su Kim, Graça Esteves, Heinz Ludwig, Saad Z Usmani, Chang-Ki Min, Ming Qi, Jon Ukropec, Brendan M Weiss, Sundararajan Vincent Rajkumar, Brian G M Durie, Jesús San F Miguel
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM). Blood cancer journal 10 (10) (2020)
Hartmut Goldschmidt, Marc-Andrea Baertsch, Jana Schlenzka, Natalia Becker, Christina Habermehl, Thomas Hielscher, Marc-Steffen Raab, Jens Hillengass, Sandra Sauer, Carsten Muller-Tidow, Steffen Luntz, Anna Jauch, Dirk Hose, Anja Seckinger, Peter Brossart, Martin Goerner, Stefan Klein, Martin Schmidt-Hieber, Peter Reimer, Ullrich Graeven, Roland Fenk, Mathias Haenel, Hans Martin, Hans W Lindemann, Christoph Scheid, Axel Nogai, Hans Salwender, Richard Noppeney, Britta Besemer, Katja Weisel, null null
Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE. Leukemia 35 (4) (2020)
Elias Karl Mai, Kaya Miah, Uta Bertsch, Jan Dürig, Christof Scheid, Katja C Weisel, Christina Kunz, Markus Munder, Hans-Walter Lindemann, Maximilian Merz, Dirk Hose, Anna Jauch, Anja Seckinger, Steffen Luntz, Sandra Sauer, Stephan Fuhrmann, Peter Brossart, Ahmet Elmaagacli, Martin Goerner, Helga Bernhard, Martin Hoffmann, Marc S Raab, Igor W Blau, Mathias Hänel, Axel Benner, Hans J Salwender, Hartmut Goldschmidt, null null
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age. Leukemia 35 (3) (2020)
Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Hartmut Goldschmidt, Pieter Sonneveld, Meletios- Athanasios Dimopoulos, Bart Heeg, Mahmoud Hashim, William Deraedt, Peter Hu, Annette Lam, Jianming He
The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison. Leukemia & lymphoma 61 (3) (2019)